PUBLIC COMPANY
save$REPLReplimune Group, Inc.
$REPLWoburn, MA, USupdated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Replimune to ride wave of physician support to launch advanced melanoma therapyAnalysts expect Replimune’s newly approved Tudriqev to reach $1.3 billion in peak sales in 2035.biospace · 1mo ago
- UniQure welcomes possible adcomm for Huntington’s asset as regulatory ‘jitters’ spread through biopharmaUniQure is ready to put its Huntington’s disease gene therapy through an advisory committee meeting—even as the broader rare disease space has been put on edge by recent FDA scrutiny of assets by R…biospace · 2mo ago
Data sources
last refreshed 44m ago
Found something off?
comments(0)
5-min edit window · permanent after that